If you have qualified potential candidates, or just want to talk more about our recruitment needs,
please contact Patricia Cristadoro, our Manager of Lateral Recruiting, at
pcristadoro@lowenstein.com.
Lowenstein Sandler seeks lateral partners to join our firm of over 350 client service-driven lawyers.
Some of the benefits of partnership at Lowenstein Sandler are:
Your practice is valued.
Your clients are a priority.
You have autonomy to grow your practice.
Your partners are committed to your success.
Your success is rewarded.
We welcome candidates who share these priorities and who can
further strengthen the work we do in key sectors, including
investment funds, life sciences, and tech. Whom do we attract?
Partners who are entrepreneurial and committed to building
successful practices. Individuals who are enthusiastic and
supportive and who want to know that their contributions will
be noticed, valued, and appreciated.
Our firm takes a diverse, inclusive approach to attracting
lateral lawyers who thrive in a firm culture that combines
collegiality and an entrepreneurial spirit.
Sophisticated restructuring practitioners or groups who regularly represent bondholders and investment funds
Transactions and Counseling
Privacy/cybersecurity
Investment management, including fund formation, compliance, and broker-dealer
Real estate finance team, preferably representing real estate funds
Life sciences transactions, including financing, capital markets, and licensing transactions on behalf of emerging-growth biotech, specialty pharma, and medical device manufacturers, as well as investors in these life sciences businesses
Litigation
Privacy/cybersecurity
White collar litigators with a recognized practice and former government experience in New York or Washington, D.C.
IP litigation team, patents including IPR (PTAB), trademark, trade secrets, and copyrights
Sophisticated litigators and groups who regularly represent investment funds, such as hedge funds and private equity funds, life science companies, and technology companies
Antitrust
Opportunistic
Candidates with strategic fit and meaningful clients in target funds, life sciences, and technology industries
We seek to further add to the diversity of our team, and we encourage you to present diverse candidates, even if they are not in the practice areas described above.
We represent clients across a wide range of industries. Please click on any of the practice and industry links below to see a representative list of matters and clients.
Represented
InSite Wireless Group, LLC
in its sale to American
Tower Corporation
(NYSE: AMT)
Represented Serial Productions
& “This American Life” (TAL)
in simultaneous deals with
The New York Times Company
as Serial was acquired and TAL
struck strategic alliance
with The Times
$170,000,000
Represented
PVH Corp. [NYSE:PVH] in its
sale of Speedo North America
Business to Pentland Group
$2,000,000,000
Represented
Indorama Ventures Public
Company Limited (BKK: IVL) in
completed acquisition of chemicals
units from Huntsman Corporation
(NYSE: HUN)
$1,400,000,000
Represented
TRANZACT and its
management team in the
sale of TRANZACT to
Willis Towers Watson
$1,700,000,000
Represented
The Estée Lauder
Companies Inc. (NYSE: ELC)
in its acquisition of
Have & Be Co. Ltd.
$100,000,000
Represented
Catalyst Investors in connection
with a follow-on investment
in the Series E funding
round of BrightFarms
$193,500,000
Represented
NexPhase Capital, LP
in sale of FAST to
Verisk Analytics, Inc.
Represented
Traub Capital in acquisition
of MANA Products
$200,000,000
Represented
Pamplona Capital Management
in growth capital equity
investment in iFit, owned by
ICON Health & Fitness
Represented
NexPhase Capital, LP in
sale of Insurance Technologies to
Thomas H. Lee Partners
Represented
New Mountain Capital and
Topix Pharmaceuticals, Inc.
in acquisition of
Think Operations, LLC
$150,000,000
Represented
Roth Capital Partners as
underwriter in a public
offering of common stock
for Loop Industries
(NASDAQ: LOOP)
$297,000,000
Represented
an investor in a note
exchange for R.R. Donnelley
(NYSE: RRD)
$150,000,000
Represented
Corbus Pharmaceuticals
Holdings, Inc. (NASDAQ: CRBP)
in an at-the-market
offering
Represented
H.C. Wainwright & Co. as
underwriter in a public
offering for Bellicum
Pharmaceuticals, Inc.
(NASDAQ: BLCM)
$150,000,000
Represented
Celldex Therapeutics, Inc.
in public offering of common stock
Represented
Roth Capital Partners
in a public offering for
Reed’s Inc. (NASDAQ: REED)
$119,000,000
Represented
Reviva Pharmaceuticals, Inc.
in merger agreement with
Tenzing Acquisition Corp.
Represented
Sonnet BioTherapeutics, Inc.
(Nasdaq: SONN) in closing of complex
merger transaction with Chanticleer
Holdings, Inc., including a $19,000,000
financing, spinoff, and Nasdaq listing
$90,000,000
Represented
Artegraft, Inc. in sale
to LeMaitre Vascular, Inc.
(Nasdaq: LMAT)
Represented
DelMar Pharmaceuticals, Inc.
(Nasdaq: DMPI) in acquisition
of Adgero Biopharmaceuticals
Holdings, Inc.
$110,000,000
Represented
Provention Bio in public
offering of common stock
$50,000,000
Represented
Matinas BioPharma
Holdings, Inc. (NYSEMKT: MTNB)
in an at-the-market
offering
Represent Official Committee
of Unsecured Creditors
Represent Official Committee
of Unsecured Creditors
Represent Official Committee
of Unsecured Creditors
Represent Official Committee
of Unsecured Creditors
Represent Official Committee
of Unsecured Creditors
Represent Official Committee
of Unsecured Creditors
Represented
New York Shipping Association Inc.
as amicus curiae in precedent-setting
dismissal of summary judgment
motion brought against N.J. Gov.
Phil Murphy in 3rd Circuit.
Secured summary judgment
on behalf of three health
care worker unions in
RICO Case
Prevailed on appeal
over property valuation
in eminent domain dispute
with Town of Kearny
Representing
PSEG to defend an
award of nuclear credits
worth approximately
$300 million every year
Representing
SBB Research Group in a
federal securities lawsuit
filed in federal district court
by the Securities and
Exchange Commission
Investigated and issued
a well-received formal report
on allegations of physical
and emotional abuse in
Rutgers University’s
softball program
Lowenstein Sandler is also responsive to client demands
for Alternative Fee Arrangements and has successfully
implemented many for our clients. To learn more about
our rates and pricing structures, please contact
Patricia Cristadoro at 646.414.6967 or
pcristadoro@lowenstein.com.
Diversity and inclusion at Lowenstein Sandler is like a chemical reaction: When the right
elements combine, possibility becomes action. We are a dynamic, interactive community of
unique individuals coming together, sharing insights, challenging limits, and working
creatively to provide the best client service and to help one another grow.
At our firm, diversity and inclusion is experienced and demonstrated every day and is
foundational to our success. It is a promise we make to each other that challenges us
to question our assumptions, embrace and explore new ideas, and commit to making
Lowenstein Sandler an outstanding place to work and build a career.
1Recruitment
We actively recruit, develop, and promote
lawyers and professional staff who bring a
wide range of perspectives and experiences to our firm.
The greatest common factor among those we recruit is a
commitment to excellence.
2Benefits
From expansive parental leave for opposite-sex
and same-sex couples to domestic partner benefits and
flextime and telecommuting options, our benefits package
is designed to support the health and wellness of all our employees.
3Career Development
When our lawyers succeed, the firm succeeds. This understanding drives us
to create an environment where employees can thrive and realize their full
potential. We support our lawyers’ professional and personal development
through innovative development programs both in-house and in collaboration
with organizations such as the Leadership Council on Legal Diversity (LCLD)
and other groups focused on building a more diverse legal community.
4Employee Resource Groups
Our five employee resource groups are forums for career development, personal enrichment, community service, and fellowship. Celebrating cultural and social diversity, these groups offer exciting programming and a space for authentic engagement for members, the firm, and the community.
We value pro bono work.
From its founding, Lowenstein Sandler has been committed to advancing the public interest and serving communities in need. The Lowenstein Center for the Public Interest embodies this commitment, directing the firm's strong pro bono program and other forms of civic and philanthropic engagement.
Through these efforts, the center addresses significant social problems and offers meaningful assistance to low-income and other vulnerable persons along with the organizations that advocate for and support them.
2019 Pro Bono Report
The 2019 Pro Bono Report provides an overview of the firm’s diverse efforts to stand beside our pro bono clients in their struggle to secure justice. Last year, Lowenstein dedicated more than 23,000 hours of pro bono work, much of which focused on immigration, civil and human rights, and criminal justice.
If you have qualified potential candidates, or just want to talk more about our recruitment needs,
please contact Patricia Cristadoro, our Manager of Lateral Recruiting, at
pcristadoro@lowenstein.com
Investment
Private 
Venture 
Life 
Technology 
Manufacturing 
Consumer 
Private 
